CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
Subscribe To Our Newsletter & Stay Updated
